60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 316.40K | 528.60K | 307.90K | 256.30K | 272.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.40K | 528.60K | 307.90K | 256.30K | 272.20K |
| Cost of Revenue | 120.70K | 537.70K | 299.90K | 480.90K | 118.10K |
| Gross Profit | 195.70K | -9.10K | 7.90K | -224.60K | 154.20K |
| SG&A Expenses | 1.47M | 1.51M | 1.61M | 1.69M | 1.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.23M | 2.85M | 1.91M | 2.17M | 2.34M |
| Operating Income | -1.92M | -2.33M | -1.60M | -1.91M | -2.07M |
| Income Before Tax | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M |
| Income Tax Expenses | -1.80K | 300.00 | 1.50K | 100.00 | -800.00 |
| Earnings from Continuing Operations | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 500.00 | 700.00 | 1.20K | 800.00 | 3.90K |
| Net Income | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M |
| EBIT | -1.92M | -2.33M | -1.60M | -1.91M | -2.07M |
| EBITDA | -1.89M | -2.30M | -1.59M | -1.89M | -2.05M |
| EPS Basic | -1.47 | -2.66 | -5.05 | -6.22 | -9.10 |
| Normalized Basic EPS | -0.84 | -1.58 | -2.94 | -3.65 | -5.34 |
| EPS Diluted | -1.47 | -2.66 | -5.05 | -6.22 | -9.10 |
| Normalized Diluted EPS | -0.84 | -1.58 | -2.94 | -3.65 | -5.34 |
| Average Basic Shares Outstanding | 1.07M | 918.90K | 368.20K | 320.90K | 239.00K |
| Average Diluted Shares Outstanding | 1.07M | 918.90K | 368.20K | 320.90K | 239.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |